Mediwhale, the AI-powered health diagnostics company, announced $12 million series A2 investments. This funding leverages the momentum of their technological advancements and rapid adoption of its innovative biomarker for preventing cardiovascular disease in general hospitals and clinics.
The financing round was led by Korea Development Bank (KDB), with participation from Woori Venture Partners,...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announces an expansion to its collaboration with Takeda that takes a data-first approach to research and development, with the aim of enhancing Takeda’s oncology research and development efforts.
After an initial collaboration...
ImmunoPrecise Antibodies, ImmunoPrecise Antibodies Ltd., an AI-driven biotherapeutic research and technology company, proudly announces the clinical progress achieved with rabbit monoclonal antibodies designed and developed using IPA’s proprietary B Cell Select® platform for the clinical-stage company, OncoResponse Inc. This achievement underscores IPA’s leadership as a Contract Research Organization creating high-quality...
Generate:Biomedicines announced a multi-target collaboration with Novartis to discover and develop protein therapeutics across multiple disease areas. The collaboration leverages Generate’s proprietary generative AI platform, “The Generate Platform,” to create potentially first- and best-in-class molecules through AI-based optimization and de novo generation.
The collaboration will combine The Generate Platform, which integrates...
XtalPi announced the official launch of XFEP and XMolGen, two proprietary software products designed to accelerate and enhance the efficiency of drug discovery. Upon this launch, XtalPi will offer commercial licenses with flexible terms for industrial and academic scientists to use the software based on their research goals. With...
XpertDox and Blue Fish Pediatrics Join Forces to Streamline Medical Coding, Enhance Clinical Documentation, and Boost Reimbursement Potential
XpertDox, a leader in AI-powered medical coding software, has partnered with Blue Fish Pediatrics, a premier provider of pediatric care in Texas. This partnership aims to transform medical coding by enhancing efficiency, accuracy,...
Asimov, the synthetic biology company advancing the design and production of therapeutics, announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design and manufacturing. The system provides gene therapy developers a single access point to an array of best-in-class...
Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, proudly announces the launch of Ginkgo Datapoints to usher in the next era of biotechnology by making the training of AI models easier and more efficient. Ginkgo Datapoints is specialized in generating large, high-quality biological datasets with a fast turnaround...
PictorLabs, a pioneering software company transforming histopathology with AI-powered virtual staining, announced the successful completion of its $30 million Series B funding round. The round was led by global software investor Insight Partners, with continued participation from M Ventures, the venture capital arm of Merck KGaA, Darmstadt, Germany, which had previously...
Arzeda, the Protein Design Company™, announced the closing of a $38M oversubscribed funding round. This fundraise brings in new investments from Sofinnova Partners, Fall Line Capital, Sucden Ventures, Silver Blue, and the venture arm of W.L. Gore & Associates (makers of Gore-Tex®), which has been in a joint development agreement with Arzeda since 2022. Previous...
